Analyst Ratings for MyoKardia (MYOK) [Buys]

MYOK Rating Summary

MYOK Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MYOK
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $225.00 (0%) * Over Last 12-Mos
Rating Score: 3.6 / 10   Percentile Rank: 32%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/20/2019 Guggenheim
» Updated 3/31/2020
Etzer Darout New Coverage Buy
(N/A)
88.00
(86.00)
55.63
(224.91)
304.3% Details
9/10/2018 Morgan Stanley
» Updated 7/15/2020
Jeffrey Hung New Coverage Overweight
(N/A)
121.00
(117.00)
61.50
(224.91)
265.71% Details
Like MYOK Ratings? Also take a look at BMY, ARA, BLUE, EXEL

MYOK Ratings News